GO:0038066 | p38MAPK cascade | 9.22e-04 | 1.00e+00 | 10.083 | 1 | 1 | 1 |
GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration | 9.22e-04 | 1.00e+00 | 10.083 | 1 | 1 | 1 |
GO:0071987 | WD40-repeat domain binding | 9.22e-04 | 1.00e+00 | 10.083 | 1 | 1 | 1 |
GO:0000922 | spindle pole | 1.67e-03 | 1.00e+00 | 4.996 | 2 | 3 | 68 |
GO:0090231 | regulation of spindle checkpoint | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 2 |
GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 2 |
GO:0072422 | signal transduction involved in DNA damage checkpoint | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 2 |
GO:0051154 | negative regulation of striated muscle cell differentiation | 2.76e-03 | 1.00e+00 | 8.499 | 1 | 1 | 3 |
GO:0090400 | stress-induced premature senescence | 2.76e-03 | 1.00e+00 | 8.499 | 1 | 1 | 3 |
GO:0007143 | female meiotic division | 2.76e-03 | 1.00e+00 | 8.499 | 1 | 1 | 3 |
GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding | 2.76e-03 | 1.00e+00 | 8.499 | 1 | 1 | 3 |
GO:0050658 | RNA transport | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 4 |
GO:0030157 | pancreatic juice secretion | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 4 |
GO:0044822 | poly(A) RNA binding | 4.01e-03 | 1.00e+00 | 2.441 | 4 | 25 | 799 |
GO:0000974 | Prp19 complex | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 5 |
GO:0051525 | NFAT protein binding | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 5 |
GO:1901741 | positive regulation of myoblast fusion | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 5 |
GO:0071204 | histone pre-mRNA 3'end processing complex | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 5 |
GO:0000930 | gamma-tubulin complex | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 5 |
GO:0060136 | embryonic process involved in female pregnancy | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 6 |
GO:0010831 | positive regulation of myotube differentiation | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 6 |
GO:0000398 | mRNA splicing, via spliceosome | 5.78e-03 | 1.00e+00 | 4.083 | 2 | 2 | 128 |
GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 6.44e-03 | 1.00e+00 | 7.276 | 1 | 1 | 7 |
GO:0004707 | MAP kinase activity | 6.44e-03 | 1.00e+00 | 7.276 | 1 | 1 | 7 |
GO:0030126 | COPI vesicle coat | 6.44e-03 | 1.00e+00 | 7.276 | 1 | 1 | 7 |
GO:0005662 | DNA replication factor A complex | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 8 |
GO:0004708 | MAP kinase kinase activity | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 8 |
GO:0019395 | fatty acid oxidation | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 8 |
GO:0032495 | response to muramyl dipeptide | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 8 |
GO:0045663 | positive regulation of myoblast differentiation | 8.27e-03 | 1.00e+00 | 6.914 | 1 | 1 | 9 |
GO:0007051 | spindle organization | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 10 |
GO:0043488 | regulation of mRNA stability | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 10 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 1.01e-02 | 1.00e+00 | 6.624 | 1 | 1 | 11 |
GO:0042770 | signal transduction in response to DNA damage | 1.01e-02 | 1.00e+00 | 6.624 | 1 | 1 | 11 |
GO:0045120 | pronucleus | 1.01e-02 | 1.00e+00 | 6.624 | 1 | 1 | 11 |
GO:0042307 | positive regulation of protein import into nucleus | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 2 | 12 |
GO:0051297 | centrosome organization | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 1 | 12 |
GO:0048205 | COPI coating of Golgi vesicle | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 1 | 12 |
GO:0015935 | small ribosomal subunit | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 4 | 12 |
GO:0051146 | striated muscle cell differentiation | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 2 | 12 |
GO:0006351 | transcription, DNA-templated | 1.17e-02 | 1.00e+00 | 2.012 | 4 | 15 | 1076 |
GO:0035371 | microtubule plus-end | 1.19e-02 | 1.00e+00 | 6.383 | 1 | 1 | 13 |
GO:0001502 | cartilage condensation | 1.19e-02 | 1.00e+00 | 6.383 | 1 | 1 | 13 |
GO:0043536 | positive regulation of blood vessel endothelial cell migration | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 1 | 14 |
GO:0005737 | cytoplasm | 1.47e-02 | 1.00e+00 | 1.306 | 6 | 39 | 2633 |
GO:0048010 | vascular endothelial growth factor receptor signaling pathway | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 1 | 16 |
GO:0043234 | protein complex | 1.50e-02 | 1.00e+00 | 3.369 | 2 | 8 | 210 |
GO:0045648 | positive regulation of erythrocyte differentiation | 1.56e-02 | 1.00e+00 | 5.996 | 1 | 1 | 17 |
GO:0005689 | U12-type spliceosomal complex | 1.56e-02 | 1.00e+00 | 5.996 | 1 | 2 | 17 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 1.56e-02 | 1.00e+00 | 5.996 | 1 | 1 | 17 |
GO:0051090 | regulation of sequence-specific DNA binding transcription factor activity | 1.65e-02 | 1.00e+00 | 5.914 | 1 | 1 | 18 |
GO:0030316 | osteoclast differentiation | 1.65e-02 | 1.00e+00 | 5.914 | 1 | 1 | 18 |
GO:0035924 | cellular response to vascular endothelial growth factor stimulus | 1.65e-02 | 1.00e+00 | 5.914 | 1 | 1 | 18 |
GO:0016020 | membrane | 1.75e-02 | 1.00e+00 | 1.846 | 4 | 25 | 1207 |
GO:0001892 | embryonic placenta development | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 1 | 20 |
GO:0032720 | negative regulation of tumor necrosis factor production | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 1 | 20 |
GO:0005761 | mitochondrial ribosome | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 1 | 20 |
GO:0000077 | DNA damage checkpoint | 1.92e-02 | 1.00e+00 | 5.691 | 1 | 1 | 21 |
GO:2000379 | positive regulation of reactive oxygen species metabolic process | 1.92e-02 | 1.00e+00 | 5.691 | 1 | 1 | 21 |
GO:0051149 | positive regulation of muscle cell differentiation | 2.01e-02 | 1.00e+00 | 5.624 | 1 | 2 | 22 |
GO:0051781 | positive regulation of cell division | 2.01e-02 | 1.00e+00 | 5.624 | 1 | 1 | 22 |
GO:0040018 | positive regulation of multicellular organism growth | 2.01e-02 | 1.00e+00 | 5.624 | 1 | 1 | 22 |
GO:0002062 | chondrocyte differentiation | 2.01e-02 | 1.00e+00 | 5.624 | 1 | 1 | 22 |
GO:0034605 | cellular response to heat | 2.01e-02 | 1.00e+00 | 5.624 | 1 | 1 | 22 |
GO:0003682 | chromatin binding | 2.12e-02 | 1.00e+00 | 3.106 | 2 | 3 | 252 |
GO:0071479 | cellular response to ionizing radiation | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 1 | 24 |
GO:0003730 | mRNA 3'-UTR binding | 2.28e-02 | 1.00e+00 | 5.440 | 1 | 1 | 25 |
GO:0006355 | regulation of transcription, DNA-templated | 2.35e-02 | 1.00e+00 | 2.187 | 3 | 9 | 715 |
GO:0010494 | cytoplasmic stress granule | 2.37e-02 | 1.00e+00 | 5.383 | 1 | 2 | 26 |
GO:0031663 | lipopolysaccharide-mediated signaling pathway | 2.46e-02 | 1.00e+00 | 5.329 | 1 | 1 | 27 |
GO:0042692 | muscle cell differentiation | 2.55e-02 | 1.00e+00 | 5.276 | 1 | 2 | 28 |
GO:0007519 | skeletal muscle tissue development | 3.00e-02 | 1.00e+00 | 5.039 | 1 | 1 | 33 |
GO:0000902 | cell morphogenesis | 3.18e-02 | 1.00e+00 | 4.954 | 1 | 1 | 35 |
GO:0006952 | defense response | 3.36e-02 | 1.00e+00 | 4.874 | 1 | 1 | 37 |
GO:0005515 | protein binding | 3.44e-02 | 1.00e+00 | 0.881 | 7 | 50 | 4124 |
GO:0051403 | stress-activated MAPK cascade | 3.81e-02 | 1.00e+00 | 4.691 | 1 | 2 | 42 |
GO:0005634 | nucleus | 4.18e-02 | 1.00e+00 | 1.004 | 6 | 40 | 3246 |
GO:0001078 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription | 4.52e-02 | 1.00e+00 | 4.440 | 1 | 1 | 50 |
GO:0034146 | toll-like receptor 5 signaling pathway | 4.52e-02 | 1.00e+00 | 4.440 | 1 | 2 | 50 |
GO:0034166 | toll-like receptor 10 signaling pathway | 4.52e-02 | 1.00e+00 | 4.440 | 1 | 2 | 50 |
GO:0018105 | peptidyl-serine phosphorylation | 4.61e-02 | 1.00e+00 | 4.411 | 1 | 2 | 51 |
GO:0003677 | DNA binding | 4.89e-02 | 1.00e+00 | 1.781 | 3 | 12 | 947 |
GO:0070062 | extracellular vesicular exosome | 4.92e-02 | 1.00e+00 | 1.403 | 4 | 28 | 1641 |
GO:0038123 | toll-like receptor TLR1:TLR2 signaling pathway | 4.96e-02 | 1.00e+00 | 4.302 | 1 | 2 | 55 |
GO:0034162 | toll-like receptor 9 signaling pathway | 4.96e-02 | 1.00e+00 | 4.302 | 1 | 2 | 55 |
GO:0038124 | toll-like receptor TLR6:TLR2 signaling pathway | 4.96e-02 | 1.00e+00 | 4.302 | 1 | 2 | 55 |
GO:0034134 | toll-like receptor 2 signaling pathway | 5.05e-02 | 1.00e+00 | 4.276 | 1 | 2 | 56 |
GO:0035666 | TRIF-dependent toll-like receptor signaling pathway | 5.13e-02 | 1.00e+00 | 4.251 | 1 | 2 | 57 |
GO:0003697 | single-stranded DNA binding | 5.13e-02 | 1.00e+00 | 4.251 | 1 | 3 | 57 |
GO:0006935 | chemotaxis | 5.22e-02 | 1.00e+00 | 4.225 | 1 | 1 | 58 |
GO:0002756 | MyD88-independent toll-like receptor signaling pathway | 5.22e-02 | 1.00e+00 | 4.225 | 1 | 2 | 58 |
GO:0034138 | toll-like receptor 3 signaling pathway | 5.31e-02 | 1.00e+00 | 4.201 | 1 | 2 | 59 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 5.31e-02 | 1.00e+00 | 4.201 | 1 | 3 | 59 |
GO:0007265 | Ras protein signal transduction | 5.31e-02 | 1.00e+00 | 4.201 | 1 | 2 | 59 |
GO:0005179 | hormone activity | 5.40e-02 | 1.00e+00 | 4.177 | 1 | 1 | 60 |
GO:0071013 | catalytic step 2 spliceosome | 5.49e-02 | 1.00e+00 | 4.153 | 1 | 1 | 61 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 5.49e-02 | 1.00e+00 | 4.153 | 1 | 2 | 61 |
GO:0000187 | activation of MAPK activity | 5.66e-02 | 1.00e+00 | 4.106 | 1 | 2 | 63 |
GO:0071222 | cellular response to lipopolysaccharide | 5.75e-02 | 1.00e+00 | 4.083 | 1 | 1 | 64 |
GO:0006928 | cellular component movement | 6.27e-02 | 1.00e+00 | 3.954 | 1 | 3 | 70 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 6.30e-02 | 1.00e+00 | 2.251 | 2 | 6 | 456 |
GO:0034142 | toll-like receptor 4 signaling pathway | 6.53e-02 | 1.00e+00 | 3.894 | 1 | 2 | 73 |
GO:0015630 | microtubule cytoskeleton | 6.71e-02 | 1.00e+00 | 3.855 | 1 | 2 | 75 |
GO:0006006 | glucose metabolic process | 7.14e-02 | 1.00e+00 | 3.762 | 1 | 2 | 80 |
GO:0030529 | ribonucleoprotein complex | 7.31e-02 | 1.00e+00 | 3.726 | 1 | 3 | 82 |
GO:0003690 | double-stranded DNA binding | 7.40e-02 | 1.00e+00 | 3.708 | 1 | 1 | 83 |
GO:0002224 | toll-like receptor signaling pathway | 7.40e-02 | 1.00e+00 | 3.708 | 1 | 2 | 83 |
GO:0007166 | cell surface receptor signaling pathway | 7.91e-02 | 1.00e+00 | 3.608 | 1 | 1 | 89 |
GO:0061024 | membrane organization | 7.91e-02 | 1.00e+00 | 3.608 | 1 | 3 | 89 |
GO:0006886 | intracellular protein transport | 7.91e-02 | 1.00e+00 | 3.608 | 1 | 1 | 89 |
GO:0032496 | response to lipopolysaccharide | 8.26e-02 | 1.00e+00 | 3.544 | 1 | 1 | 93 |
GO:0010467 | gene expression | 8.35e-02 | 1.00e+00 | 2.020 | 2 | 17 | 535 |
GO:0000086 | G2/M transition of mitotic cell cycle | 8.60e-02 | 1.00e+00 | 3.484 | 1 | 3 | 97 |
GO:0005198 | structural molecule activity | 8.94e-02 | 1.00e+00 | 3.425 | 1 | 1 | 101 |
GO:0003735 | structural constituent of ribosome | 9.61e-02 | 1.00e+00 | 3.315 | 1 | 8 | 109 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 9.66e-02 | 1.00e+00 | 1.899 | 2 | 9 | 582 |
GO:0042981 | regulation of apoptotic process | 9.87e-02 | 1.00e+00 | 3.276 | 1 | 4 | 112 |
GO:0016607 | nuclear speck | 1.07e-01 | 1.00e+00 | 3.153 | 1 | 2 | 122 |
GO:0031965 | nuclear membrane | 1.14e-01 | 1.00e+00 | 3.061 | 1 | 2 | 130 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 1.15e-01 | 1.00e+00 | 1.753 | 2 | 8 | 644 |
GO:0030168 | platelet activation | 1.23e-01 | 1.00e+00 | 2.944 | 1 | 3 | 141 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 1.24e-01 | 1.00e+00 | 2.934 | 1 | 4 | 142 |
GO:0001525 | angiogenesis | 1.27e-01 | 1.00e+00 | 2.894 | 1 | 2 | 146 |
GO:0001701 | in utero embryonic development | 1.33e-01 | 1.00e+00 | 2.817 | 1 | 2 | 154 |
GO:0008380 | RNA splicing | 1.42e-01 | 1.00e+00 | 2.717 | 1 | 4 | 165 |
GO:0007067 | mitotic nuclear division | 1.42e-01 | 1.00e+00 | 2.717 | 1 | 5 | 165 |
GO:0007283 | spermatogenesis | 1.45e-01 | 1.00e+00 | 2.691 | 1 | 2 | 168 |
GO:0016071 | mRNA metabolic process | 1.46e-01 | 1.00e+00 | 2.674 | 1 | 11 | 170 |
GO:0006412 | translation | 1.53e-01 | 1.00e+00 | 2.608 | 1 | 13 | 178 |
GO:0016070 | RNA metabolic process | 1.61e-01 | 1.00e+00 | 2.529 | 1 | 11 | 188 |
GO:0004674 | protein serine/threonine kinase activity | 1.68e-01 | 1.00e+00 | 2.461 | 1 | 3 | 197 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 1.69e-01 | 1.00e+00 | 2.447 | 1 | 2 | 199 |
GO:0035556 | intracellular signal transduction | 1.69e-01 | 1.00e+00 | 2.447 | 1 | 3 | 199 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 1.72e-01 | 1.00e+00 | 2.418 | 1 | 1 | 203 |
GO:0005813 | centrosome | 1.83e-01 | 1.00e+00 | 2.322 | 1 | 6 | 217 |
GO:0043231 | intracellular membrane-bounded organelle | 1.84e-01 | 1.00e+00 | 2.315 | 1 | 1 | 218 |
GO:0005654 | nucleoplasm | 1.90e-01 | 1.00e+00 | 1.309 | 2 | 16 | 876 |
GO:0003723 | RNA binding | 2.06e-01 | 1.00e+00 | 2.135 | 1 | 6 | 247 |
GO:0005829 | cytosol | 2.18e-01 | 1.00e+00 | 0.865 | 3 | 33 | 1787 |
GO:0008285 | negative regulation of cell proliferation | 2.28e-01 | 1.00e+00 | 1.970 | 1 | 3 | 277 |
GO:0006468 | protein phosphorylation | 2.46e-01 | 1.00e+00 | 1.850 | 1 | 3 | 301 |
GO:0000278 | mitotic cell cycle | 2.55e-01 | 1.00e+00 | 1.789 | 1 | 9 | 314 |
GO:0007596 | blood coagulation | 2.72e-01 | 1.00e+00 | 1.678 | 1 | 4 | 339 |
GO:0006366 | transcription from RNA polymerase II promoter | 2.74e-01 | 1.00e+00 | 1.670 | 1 | 2 | 341 |
GO:0048471 | perinuclear region of cytoplasm | 2.76e-01 | 1.00e+00 | 1.657 | 1 | 7 | 344 |
GO:0005730 | nucleolus | 3.11e-01 | 1.00e+00 | 0.834 | 2 | 21 | 1217 |
GO:0006915 | apoptotic process | 3.21e-01 | 1.00e+00 | 1.400 | 1 | 4 | 411 |
GO:0045087 | innate immune response | 3.47e-01 | 1.00e+00 | 1.263 | 1 | 6 | 452 |
GO:0007165 | signal transduction | 4.45e-01 | 1.00e+00 | 0.812 | 1 | 5 | 618 |
GO:0005615 | extracellular space | 4.63e-01 | 1.00e+00 | 0.737 | 1 | 2 | 651 |
GO:0005739 | mitochondrion | 4.67e-01 | 1.00e+00 | 0.719 | 1 | 4 | 659 |
GO:0005524 | ATP binding | 5.78e-01 | 1.00e+00 | 0.283 | 1 | 10 | 892 |
GO:0046872 | metal ion binding | 5.96e-01 | 1.00e+00 | 0.216 | 1 | 10 | 934 |
GO:0005886 | plasma membrane | 8.37e-01 | 1.00e+00 | -0.717 | 1 | 13 | 1784 |